(Q57252632)

English

Combination antithymocyte globulin and soluble TNFα inhibitor (etanercept) +/− mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease

scientific article published on 08 May 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) +/- mycophenolate mofetil for treatment of steroid refractory acute graft-versus-host disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Geoffrey R Hill

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

G A Kennedy

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Butler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

R Western

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

J Morton

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

S Durrant

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

0 references

publication date

8 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1143-1147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16699531%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705380

0 references

Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Infliximab for steroid‐refractory acute GVHD: A case series

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Infliximab for the treatment of severe steroid refractory acute graft-versus-host disease in three patients after allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

21 January 2018

Etanercept in graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705380

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57252632&oldid=2145018265"